Yizhuo Li

机构：Chinese University of Hong Kong, ShangHai JiAi Genetics & IVF Institute, First Affiliated Hospital of Henan University, Shanghai Artificial Intelligence Laboratory, China Medical University · ORCID：0000-0003-4214-8305

发表论文 64 篇 · 总被引 1452 次 · h-index 20

代表论文

• Neoadjuvant chemo-immunotherapy with camrelizumab plus nab-paclitaxel and cisplatin in resectable locally advanced squamous cell carcinoma of the head and neck: a pilot phase II trial (2024 · Nature Communications · 被引 105)
• XELOX (capecitabine plus oxaliplatin) plus bevacizumab (anti-VEGF-A antibody) with or without adoptive cell immunotherapy in the treatment of patients with previously untreated metastatic colorectal cancer: a multicenter, open-label, randomized, controlled, phase 3 trial (2024 · Signal Transduction and Targeted Therapy · 被引 35)
• RUNX1 promotes proliferation and migration in non‐small cell lung cancer cell lines via the mTOR pathway (2023 · The FASEB Journal · 被引 15)
• Silencing lncRNA‐DARS‐AS1 suppresses nonsmall cell lung cancer progression by stimulating miR‐302a‐3p to inhibit ACAT1 expression (2024 · Molecular Carcinogenesis · 被引 7)
• Cooling outweighs warming across phenological transitions in the Northern Hemisphere (2025 · Proceedings of the National Academy of Sciences · 被引 6)
• Dynamic identification of snow phenology in the Northern Hemisphere (2025 · ˜The œcryosphere · 被引 3)